文摘
Childhood onset dystonia is frequently progressive, with worsening towards generalization and consequent disability. GPi DBS is efficient in isolated dystonia, subcortical myoclonus, dystonic tremor and tics; STN and motor thalamic nuclei are under exploration. In acquired dystonia, neurometabolic and degenerative disorders, DBS role deserves exploration to confirm as an efficient and lasting therapy. The choice of neuromodulatory DBS parameters could influence not only the initial therapeutic outcome but also its maintenance over time. DBS opens a new window towards a better understanding of the physiology of different movement and psychiatric disorders.